Janney Montgomery Scott LLC Raises Stake in Maximus, Inc. (NYSE:MMS)

Janney Montgomery Scott LLC boosted its holdings in shares of Maximus, Inc. (NYSE:MMS) by 79.7% during the 4th quarter, HoldingsChannel reports. The firm owned 5,949 shares of the health services provider’s stock after purchasing an additional 2,638 shares during the period. Janney Montgomery Scott LLC’s holdings in Maximus were worth $444,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors also recently bought and sold shares of MMS. Assenagon Asset Management S.A. grew its position in Maximus by 277.0% during the 3rd quarter. Assenagon Asset Management S.A. now owns 878,894 shares of the health services provider’s stock worth $81,878,000 after purchasing an additional 645,760 shares during the last quarter. Reinhart Partners LLC. grew its position in Maximus by 43.5% during the 4th quarter. Reinhart Partners LLC. now owns 551,146 shares of the health services provider’s stock worth $41,143,000 after purchasing an additional 167,019 shares during the last quarter. Sio Capital Management LLC purchased a new position in Maximus during the 3rd quarter worth $14,453,000. Barclays PLC grew its position in Maximus by 285.1% during the 3rd quarter. Barclays PLC now owns 170,971 shares of the health services provider’s stock worth $15,927,000 after purchasing an additional 126,573 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. grew its position in Maximus by 12.4% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 929,066 shares of the health services provider’s stock worth $86,552,000 after purchasing an additional 102,350 shares during the last quarter. 97.21% of the stock is owned by hedge funds and other institutional investors.

Maximus Stock Down 0.2 %

Shares of NYSE:MMS opened at $69.86 on Monday. The company has a market cap of $3.99 billion, a price-to-earnings ratio of 15.02 and a beta of 0.72. The firm’s 50-day simple moving average is $74.73 and its 200-day simple moving average is $83.27. The company has a quick ratio of 1.49, a current ratio of 1.72 and a debt-to-equity ratio of 0.82. Maximus, Inc. has a fifty-two week low of $68.30 and a fifty-two week high of $93.97.

Maximus (NYSE:MMS) last issued its earnings results on Thursday, February 6th. The health services provider reported $1.61 earnings per share for the quarter, beating the consensus estimate of $1.39 by $0.22. Maximus had a net margin of 5.28% and a return on equity of 21.95%. As a group, equities research analysts predict that Maximus, Inc. will post 6.05 earnings per share for the current year.

Maximus Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 28th. Investors of record on Saturday, February 15th will be paid a $0.30 dividend. This represents a $1.20 annualized dividend and a dividend yield of 1.72%. The ex-dividend date is Friday, February 14th. Maximus’s dividend payout ratio (DPR) is 25.81%.

Wall Street Analysts Forecast Growth

Several brokerages have recently weighed in on MMS. StockNews.com raised shares of Maximus from a “hold” rating to a “buy” rating in a report on Thursday. Raymond James raised shares of Maximus from a “market perform” rating to an “outperform” rating and set a $90.00 target price on the stock in a report on Thursday, January 2nd.

Insider Activity at Maximus

In related news, insider Michelle F. Link sold 2,208 shares of the firm’s stock in a transaction dated Tuesday, December 3rd. The shares were sold at an average price of $73.83, for a total value of $163,016.64. Following the completion of the sale, the insider now owns 6,567 shares in the company, valued at $484,841.61. This trade represents a 25.16 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Raymond B. Ruddy bought 3,490 shares of the business’s stock in a transaction on Thursday, December 12th. The shares were acquired at an average price of $71.46 per share, with a total value of $249,395.40. Following the transaction, the director now owns 112,520 shares of the company’s stock, valued at $8,040,679.20. The trade was a 3.20 % increase in their position. The disclosure for this purchase can be found here. Insiders purchased 7,063 shares of company stock worth $502,017 over the last 90 days. Company insiders own 1.60% of the company’s stock.

Maximus Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.